Inhibition of regeneration and induction of healing are classic outcomes of tissue repair in adult mammals. Here, by using gain and loss of function experiments, we demonstrate that both endogenous and exogenous opioids prevent tissue regeneration in adults, by inhibiting the early reactive oxygen species (ROS) production occurring after lesion and required for regeneration. These effects can be overcome and regeneration induced by the use of an opioid antagonist. These results, obtained in both gold-standard adult zebrafish and a newly-developed model of regeneration in adult mammals, demonstrate that this mechanism can be considered as a general paradigm in vertebrates. In addition, we show that opioids act via signaling through peripheral mu-receptors expressed on granulocytes. This work clearly demonstrates the deleterious role of opioids on tissue regeneration through the control of ROS production in vertebrates and thus questions about opioid-based analgesia in perioperative care.
INTRODUCTION
Wound healing or regeneration are two opposite ways of tissue repair that take place after injury. While occurring in lower vertebrates and newborn mammals, regeneration after massive resection is largely impaired in adult mammals that instead exhibit wound healing 1 . First line of defence immediately induced after the injury, inflammation plays a crucial role in the outcome of injury. Inflammation generates a well-known cascade of immune events, among which early recruitment of myeloid cells notably granulocytes on the injured site, and release of detersive molecules, as reactive oxygen species (ROS), cytokines and matrix molecules. The beneficial effect of ROS on regeneration has been mainly described in the adult zebrafish 2-5 , newt 6 , planarian 7 , gecko 8 and xenopus tadpole 9 .
After injury, inflammation is also associated with the peripheral release of endogenous opioid peptides by immune cells infiltrating injured tissue or neural cells 10 . In this context, opioids play both anti-inflammatory and analgesic roles by binding to opioid receptors on immune and neural cells 11, 12 . Opioid analogues are therefore commonly used as exogenous agents for systematic peri-operative care procedures of pain relief 13, 14 and for chronic pain management, including inflammatory symptoms and lesions [15] [16] [17] . Surprisingly the consequences of their administration on regeneration have been poorly investigated, and conflicting results have been reported in animal models with a moderate epithelium injury 18, 19 , 20 , 21 .
Often investigated and considered as a therapeutic target for its key role in energy homeostasis, inguinal fat pad (IFP) is a complex tissue that displays high plasticity in adults as it can undergo phenotypic (browning) or size (expansion or reduction) modifications, depending on the metabolic context 22, 23 . It hosts a large pool of regenerative mesenchymal stem/stromal cells widely tested for their regenerative capacities in numerous clinical trials 24, 25 . Located just under the skin, subcutaneous IFP thus represents a relevant model to study organ plasticity in adult mammals.
We hypothesized that opioids are the key factors that direct tissue injury outcome towards regeneration or healing through their control of ROS production by immune cells. To test this hypothesis, we developed gain and loss of function experiments in MRL mice well-known for their regenerative capabilities 26 and in non-regenerative C57BL/6 mice. In a newly-developed model of tissue lesion, relying on massive resection of IFP, we show here that following injury, opioids prevent regeneration through inhibition of ROS production. This mechanism also occurs in the caudal fin of zebrafish suggesting that it can be considered as a general paradigm in vertebrates.
Opioids effects are mediated through their specific binding to mu receptors on granulocytes. Altogether our results provide a new mechanism for the inhibition of regeneration in adults, and question about the use of opioids in post-operative care.
RESULTS

Massive resection of IFP induces tissue regeneration or healing in MRL and
C57BL/6 adult mice respectively
To investigate the cellular processes occurring in regeneration vs healing in mammals, we developed a robust and quantifiable model of tissue regeneration or healing, relying on the massive resection (around 35% of the whole tissue) of the inguinal fat pad (IFP) in adult mice. Using the specific anatomy of the IFP, the resection was systematically performed adjacent to the lymph node used as a visual reference allowing the reproducibility of the resection (Figure supplement 1A) .
Macroscopic and microscopic observations as well as IFP weight quantification were performed 8 weeks after surgery. As expected, spontaneous macroscopic regeneration was observed in MRL mice in contrast to C57bl/6 mice that exhibit healing ( Figure 1A ). Regenerative IFP exhibited adipocytes, blood vessels and nerves organized in typical shape and structure similar to the ones observed in the contralateral IFP used as an internal control. In contrast, healing IFP was characterized by the absence of adipocytes and high collagen deposition (fibrosis) revealed by second harmonic imaging ( Figure 1B ). Regeneration was then quantified by the regeneration index (RI) i.e. the weight ratio between the resected IFP and the uninjured contralateral IFP, having previously controlled that uninjured IFP weight did not change over the same time following unilateral IFP resection (Figure supplement 1B). Consistent with macroscopic and microscopic observations, 8 weeks after resection, RI was significantly higher in regenerative IFP than in healing IFP (0.94±0.037 vs 0.69±0.017 respectively) ( Figure 1C ). Same results were obtained as soon as 2 and 4 weeks after resection (Figure supplement 1C) and no further regeneration was observed in C57Bl/6 mice, even one year after resection (data not shown). According to these results, this newly-developed tissue lesion can be used to decipher regeneration and healing regulatory processes.
Opioid signaling controls IFP regeneration
To investigate whether opioids inhibit regeneration and/or induce healing, spontaneous regenerative MRL mice and non-regenerative C57Bl/6 mice were treated with an opioid receptor agonist (tramadol, TRAM), or antagonist (naloxone methiodide, NAL-M) respectively. TRAM treatment induced a significant decrease in RI 4 weeks after resection (Figure 2A ; 0.79±0.02 vs. 0.65±0.030, without vs with TRAM respectively). In contrast, RI was significantly higher in NAL-M treated mice compared to untreated mice as soon as 2 weeks after resection ( Figure 2B ; 0.67±0.007 vs 0.75±0.024 in untreated vs treated mice respectively), and this effect was amplified after 4 weeks (RI 0.69±0.013 vs 0.84±0.009, without vs with NAL-M treatment respectively) ( Figure supplement 2A, 2B ). Altogether, these results demonstrate that exogenous and endogenous opioids inhibit spontaneous tissue regeneration and favour tissue healing. Since NAL-M does not cross the blood-brain barrier, our results suggest that the anti-regenerative effect of opioids were mediated through peripheral opioid receptors.
Considering the implication of mu-opioid receptor (MOR) isoforms in the antiinflammatory effect of opioids 27, 28 , the involvement of MOR in regeneration was examined using MOR-deficient mice (MOR-KO). 2 weeks after resection, RI of MOR-KO mice was significantly higher compared to untreated C57BL/6 mice (0.85±0.022 vs 0.67±0.007 in MOR-KO vs untreated C57BL/6 mice respectively; Figure 2B) indicating that IFP regeneration occurred in the absence of MOR. Treatment of MOR-KO mice with NAL-M had no additional effect on regeneration (data not shown), suggesting that NAL-M exerts its effects only through MOR.
We thus postulated that the absence of spontaneous regeneration in C57BL/6 compared to MRL mice could be associated with a higher tonus of endogenous opioids in the IFP of C57BL/6 mice. Consistent with this hypothesis, the IFPexpression of proenkephalin (PENK, enkephalin opioid peptide precursor) was significantly higher in IFP of C56Bl/6 than in MRL mice ( Figure 2C ). In contrast, neither prodynorphyn (PDYN, dynorphine opioid peptide precursor) nor pro-opiomelanocortin (POMC, endorphine opioid peptide precursor) mRNA were detected in IFP in both mice strains (data not shown).
Altogether these data demonstrate that opioids inhibit regeneration in adult mammals through the peripheral MOR. This effect could be mediated by endogenous PENK.
Opioid signaling prevents regeneration through control of ROS levels in zebrafish
To demonstrate that the anti-regenerative effects of opioids were not tissue and/or model dependent, we used the gold-standard adult zebrafish caudal fin regeneration model 29 . Fish were incubated in NAL-M or TRAM from the time of amputation to analysis, and the size of the regenerate was quantified after amputation ( Figure 3A ).
As in our mice model, NAL-M enhanced the regenerate size ( Figure 3B , 3C, 137.7%±26), while TRAM inhibited regeneration ( Figure 3B , 3C, 70±13%).
These results demonstrate that inhibitory effect of exogenous and endogenous opioids on tissue regeneration is a prevailing process in adult vertebrates.
In zebrafish, regeneration has been widely demonstrated to be controlled by ROS 3 .
We thus postulated that opioids control caudal fin regeneration through regulation of ROS production. NAL-M treatment enhanced ROS levels at the tip of the amputated fin, the major site of ROS production after amputation ( Figure 3D , 3E) while TRAM reduced the overall ROS production, even when the area of ROS detection was extended compared to the control ( Figure 3D , 3E). These results obtained in the caudal fin of zebrafish demonstrate that opioids inhibit tissue regeneration via abolishing the transient ROS peak.
Opioid signaling prevents regeneration through control of ROS levels in adult mammals
We therefore aimed to demonstrate that regeneration in adult mammals was associated with ROS production. In line with this hypothesis, IFP resection induced a robust and transient peak of ROS in the injured tissue of regenerative MRL mice and not C57Bl/6 mice as shown by in vivo imaging using luminol ( Figure 4A ). ROS production in MRL mice reached maximal values at 12 hours after resection and returned to normal values 72 hours following surgery ( Figure 4B ). MRL mice treatment with apocynin (APO, inhibitor of NADPH p47 phox subunit translocation 30 after IFP resection, induced a severe decrease in RI 2 weeks after surgery ( Figure   4C ; 0.85±0.027 vs. 0.62±0.019 in untreated vs APO treated IFP). These results demonstrate that a robust and transient peak of ROS is required for proper tissue regeneration in adult MRL mice.
The effects of opioids on ROS production were then investigated in vivo by treatments with antagonists or agonists of opioid receptors. In vivo imaging revealed that the ROS peak observed after resection was strongly inhibited in IFP of MRL mice within 96 hours after TRAM treatment ( Figure 4D ), and this was associated with a reduced RI ( Figure 2A ). In contrast, NAL-M treatment of C57Bl/6 mice induced a significant increase in ROS production and subsequent increase in RI, 2 weeks postresection ( Figure 4E , 4F). This opioid effect on ROS production was abolished after APO treatment, leading to a severe decrease in RI ( Figure 4E , 4F).
Taken together, these data demonstrate that ROS production is required for proper tissue regeneration in adult mammals and that opioids inhibit this regeneration through the control of ROS production.
Mu-opioid receptors on granulocytes mediate opioids anti-regenerative effect
Several evidences suggest that immune cells may be necessary to induce regeneration [31] [32] [33] . Immune cells were therefore quantified in the IFP, in both MRL and C57Bl/6 mice after resection. Flow cytometry analysis of the IFP area located close to the wound showed that the number of granulocytes (CD45 + /Gr-1 + ) was significantly increased in NAL-M treated mice compared to untreated mice whereas no change in macrophages (CD45 + /CD11b + /F4/80 + ) or mast cell (CD45 + /CD11b -/CD117 + /FcRI + ) populations was detected ( Figure 5A ). This indicates that IFP regeneration correlates with accumulation of granulocytes. Specific depletion of this cell population was thus undertaken before resection and NAL-M treatment in C57BL/6 mice. Injection of an anti Gr-1 blocking antibody induced a significant and specific decrease in Gr-1 + cell number in IFP within 24 hours (Figure supplement 3A) whereas no significant change in mast cells and macrophages numbers was observed. In the absence of granulocytes, the ROS production after IFP resection and NAL-M-treatment was severely decreased ( Figure 5B ) as well as the RI (0.61±0.03) ( Figure 5C ). This suggests that granulocytes play a key role in the control of regeneration via the production of ROS.
Finally, to determine whether opioids exert a direct effect on granulocytes, Gr1 + and Gr1cells were sorted from C57Bl/6 mice 6 hours after IFP resection with or without NAL-M treatment ( Figure 5D ). In vitro ROS production was quantified by using luminol. Gr-1 + cell sorted from NAL-M treated mice exhibited a significant higher ROS production than Gr-1 + cells sorted from untreated mice ( Figure 5E Altogether, these data clearly demonstrate a direct inhibitory effect of opioids on ROS production by Gr1 + cells after IFP resection, leading to inhibition of IFP regeneration.
DISCUSSION
By using convergent and complementary models, and loss and gain of function approaches, we show for the first time in adult mammals, that in the early steps postinjury opioids prevent regeneration processes via the inhibition of an early burst of ROS produced by granulocytes, through a signaling via mu-receptors.
A transient but early use of an opioid receptor agonist is sufficient to inhibit spontaneous regeneration of the IFP in the regenerative strain of mice MRL, when treatment with an antagonist is able to induce regeneration in the non-regenerative strain of mice C57BL/6. This is in line with a very recent study suggesting that administration of morphine (opioid receptor agonist) delays pancreatic regeneration after acute pancreatitis in mice 34 . However, our data demonstrates also that endogenous opioids are key determinant in regeneration control. Indeed, endogenous PENK expression is lower in regenerative MRL vs non regenerative C57Bl/6 mice. In addition, blocking endogenous opioid receptors (without any administration of exogenous opioids) is sufficient to induce tissue regeneration.
We show here that a strong production of ROS by NADPH oxidation occurs both in the spontaneous and the pharmacologically-induced regeneration processes and that its inhibition systematically prevents tissue regeneration in adult mice. We show that this strong production of ROS is a very early and transient phenomenon. This is the first demonstration of the crucial role of ROS in the control of regeneration in adult mammals. In agreement with our data, a correlation between ROS production and regeneration was described in adult acomys mice 33 . In addition, several reports have highlighted the importance of ROS in regeneration in invertebrates and lower vertebrates 3, 9, 35 . Altogether, this shows that ROS requirement for proper regeneration is a general paradigm in vertebrates including adult mammals.
Our findings support an anti-oxidative effect (inhibition of ROS production) of endogenous opioids in vivo after tissue lesion that prevents regeneration. In vivo such a role of opioids has never been described. An opposite effect of long term opioid treatment was however described in cultured cells (for review see 36 ).
Interestingly, our data demonstrate the inhibitory role of opioids on regeneration, through the inhibition of ROS production in different tissues (IFP and caudal fin) and animal models (mice and zebrafish), showing that this mechanism is not tissue or model specific, and can be considered as a general paradigm in vertebrates.
Our data undoubtedly show that granulocytes play a key role in the very early steps of regeneration in mammals. Granulocytes, notably neutrophils are among the first immune cells to infiltrate injured tissue. Their role in regeneration has been suggested in zebrafish 37 , but remains controversial. They have also been shown to be the principal regulators of optic nerve regeneration in mice 38 . In view of the increased number of granulocytes at the site of lesion after NAL-M treatment, we can speculate that endogenous opioids through activation of the Gi-protein coupled MOR prevent chemokine secretion required for granulocytes recruitment as it was described after morphine treatment 27 . Although granulocytes are the only cells to accumulate in the first hours after IFP resection, it does not rule out a possible role for other immune cells in the whole process. Indeed, macrophages have been shown to be involved in regeneration in mammals, at least 48 hours after lesion 32, 33 suggesting that macrophages are enrolled at later stage of regeneration process.
In conclusion, we demonstrate a pivotal role of opioids in the tissue repair outcome after lesion in adult vertebrates. Both endogenous and exogenous opioids inhibit regeneration very early in the process via inhibition of granulocytes ROS generation.
These effects can be reversed using opioid receptor antagonists. Considering that all peripheral tissues potentially contain endogenous opioids after lesion and their receptors, we propose that these results could have broad implication for mammalian tissue repair and regeneration. Finally, opioids are largely used in peri-operative care in human, and their potential role on tissue repair outcome has never been questioned. Our results open therefore new perspectives to develop new and proregenerative perioperative care protocols that could enhance tissue regeneration while preventing pain and inflammation.
MATERIALS AND METHODS
Animals
All experiments in mice were performed on 5-to 7-weeks-old male mice. For granulocyte cells isolation, magnetic sorting was used: 6 hours after IFP resection, SVF from adipose tissue was prepared; cells were incubated with 10 µl of anti-Gr-1 microbeads (Miltenyi Biotec, 130-092-332) and sorted with MACSQuant Tyto (Miltenyi biotec). Gr1 + and Gr1cells were maintained in HBSS during ROS level quantification by luminometer.
In vitro ROS quantification
The oxygen-dependent respiratory production of 140 000 AT Gr1or Gr1 + sorted cells was measured by chemiluminescence in the presence of luminol (66 μM, Sigma-Aldrich) using a thermostatically monitored luminometer (37°C) (210410A 
Figure legends
